SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-302560
Filing Date
2019-11-27
Accepted
2019-11-27 16:15:58
Documents
7
Period of Report
2019-11-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d568301d8k.htm 8-K 23930
2 EX-1.1 d568301dex11.htm EX-1.1 193652
3 EX-5.1 d568301dex51.htm EX-5.1 8090
4 EX-99.1 d568301dex991.htm EX-99.1 8462
5 EX-99.2 d568301dex992.htm EX-99.2 9062
6 GRAPHIC g568301g1127065834005.jpg GRAPHIC 4322
7 GRAPHIC g568301g1127065834145.jpg GRAPHIC 6119
  Complete submission text file 0001193125-19-302560.txt   259163
Mailing Address LYONDELLBASELL TOWER 1221 MCKINNEY STREET, SUITE 3200 HOUSTON TX 77010
Business Address LYONDELLBASELL TOWER 1221 MCKINNEY STREET, SUITE 3200 HOUSTON TX 77010 936-355-1910
Aravive, Inc. (Filer) CIK: 0001513818 (see all company filings)

IRS No.: 264106690 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36361 | Film No.: 191258080
SIC: 2834 Pharmaceutical Preparations